The sum of all browning in FGF21 therapeutics.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 26039444.
- Also identified by DOI 10.1016/j.cmet.2015.05.018.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
FGF21 mimetics are a promising therapeutic tool, believed to exert their anti-obesity effect partly through browning of white fat. Véniant et al. (2015) and Samms et al. (2015) present evidence arguing against fat browning as the primary mechanism causal to weight loss following FGF21-based treatment in mice.
Medical subject headings
- Adipose Tissue, White
- Anti-Obesity Agents
- Fibroblast Growth Factors
- Obesity